Showing results (901-910 of 1,211) with videos related to
Sort By:
Pageof 122
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2026
Finerenone and eGFR slope across Different Levels of Baseline Albuminuria and Estimated Glomerular Filtration Rate: Insights from FINEARTS-HFFinnian R Mc Causland, Hiddo J L Heerspink, Muthiah Vaduganathan, et al.American Heart Journal|May 13, 2015
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placeboRhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 9, 2009
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, et al.Journal of the American Medical Informatics Association : JAMIA|December 13, 2024
Effectiveness of electronic medical record-based strategies for death and hospital admission endpoint capture in pragmatic clinical trialsMaryam Rahafrooz, Danne C Elbers, Jay R Gopal, et al.Journal of the American College of Cardiology|March 27, 2024
Dapagliflozin and Days of Full Health Lost in the DAPA-HF TrialToru Kondo, Ulrik M Mogensen, Atefeh Talebi, et al.American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.Hypertension (Dallas, Tex. : 1979)|December 4, 2023
Cardiac Abnormalities in Hispanic/Latina Women With Prior De Novo Hypertensive Disorders of PregnancyOdayme Quesada, Shathiyah Kulandavelu, Catherine J Vladutiu, et al.Journal of the American College of Cardiology|October 1, 2024
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF TrialAkshay S Desai, Muthiah Vaduganathan, Brian L Claggett, et al.European Journal of Heart Failure|September 20, 2024
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trialMaria A Pabon, Muthiah Vaduganathan, Brian L Claggett, et al.Journal of the American Heart Association|December 24, 2024
Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HFSimone Solano, Mingming Yang, Paolo Tolomeo, et al.Pageof 122